Immunogenicity and plasmid delivery pathways of non-invasive Lactococcus lactis -vectored mucosal DNA vaccination
Open Access
- 13 January 2026
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 94 (1) , e0046025
Abstract
Mucosal DNA vaccination using a non-invasive Lactococcus lactis (LL) vector has been investigated. However, its immunogenicity and plasmid transfer mechanisms remain largely unknown. In this study, we investigated the intranasal delivery of LL carrying a mammalian enhanced green fluorescent protein (EGFP)-expressing plasmid and the cellular pathways underlying DNA transfer. Intranasally administered LL was primarily localized on the nasal epithelial surfaces, and a smaller fraction penetrated the subepithelial tissues. Intranasal administration of LL-carrying pLEC-EGFP plasmid induces antigen-specific serum IgG and mucosal IgA responses. In vitro co-culture analyses demonstrated that plasmid delivery and expression occurred in phagocytic cell lines but not in epithelial cell lines. This transfer was inhibited by compounds specific for phagocytosis, consistent with the observed time course of DNA transfer and localization of LL within Lamp-1 + phagolysosomes. In contrast, compounds for bactericidal mechanisms, including lysosomal acidification, reactive oxygen species, and reactive nitrogen species, did not affect DNA transfer. As our findings suggest that phagocytosis is the primary pathway for plasmid delivery by non-invasive LL vectors in cell culture assays, further studies to confirm these findings in animal models are warranted to develop new strategies for improved LL-based mucosal DNA vaccines.Keywords
Funding Information
- Japan Society for the Promotion of Science (22K07071)
- Japan Society for the Promotion of Science (JP19K16649)
- Lactic Acid Bacteria Foundation
This publication has 45 references indexed in Scilit:
- DNA Vaccines: History, Molecular Mechanisms and Future PerspectivesJournal of Molecular Biology, 2023
- Improved DNA delivery using invasive E. coli DH10B in human cells by modified bactofection methodJournal of Controlled Release, 2021
- Recombinant invasive Lactococcus lactis can transfer DNA vaccines either directly to dendritic cells or across an epithelial cell monolayerVaccine, 2015
- Lactic acid bacteria—20 years exploring their potential as live vectors for mucosal vaccinationApplied Microbiology and Biotechnology, 2015
- Inhibitory Mechanism of 10-Hydroxy-trans-2-decenoic Acid (Royal Jelly Acid) Against Lipopolysaccharide- and Interferon-β-Induced Nitric Oxide ProductionInflammation, 2012
- Characterization of PrPSc transmission from immune cells to neuronal cellsCellular Immunology, 2012
- Listeria as a vaccine vectorMicrobes and Infection, 2007
- Dynasore, a Cell-Permeable Inhibitor of DynaminDevelopmental Cell, 2006
- Internalin-expressing Lactococcus lactis is able to invade small intestine of guinea pigs and deliver DNA into mammalian epithelial cellsMicrobes and Infection, 2005
- GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene deliveryAdvanced Drug Delivery Reviews, 2004